NCT03269435

Greater Occipital Nerve Block Versus Metoclopramide

A Randomized Trial of Greater Occipital Nerve Block With Bupivacaine Versus Intravenous Metoclopramide for Acute Migraine

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 99 (actual)
• Sponsor: Montefiore Medical Center · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

We are comparing a type of nerve block called greater occipital nerve block versus standard therapy among patients who present to an emergency department for acute migraine. This is a randomized, double-blind, double dummy study. The greater occipital nerve block will be performed bilaterally with bupivacaine 0.5%. Standard therapy is metoclopramide 10mg IV.

Conditions

• Migraine

Interventions

Type	Name	Description
PROCEDURE	Greater occipital nerve block with bupivacaine	This is a type of peripheral nerve block. 3cc of 0.5% bupivacaine will be injected adjacent to the greater occipital nerve block blaterally
DRUG	Metoclopramide	Metoclopramide 10mg IV will be administered over 15 minutes

Timeline

• Start date: 2017-11-01
• Primary completion: 2020-03-21
• Completion: 2020-03-21
• First posted: 2017-08-31
• Last updated: 2021-09-22
• Results posted: 2021-09-22

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study